EIR Nektar Therapeutics Feb 2019

Dustin Abaonza FDA, Cara Alfaro FDA$595.00 - Available Now

FDA investigators audited the Nektar Therapeutics - San Francisco, CA, United States facility and issued inspectional observation (via FDA 483) on 01 Feb 2019.

Product details

  • Category:
  • Inspection end: 01 Feb 2019
  • Location: San Francisco, United States
  • FEI: 3008943810
Add To Cart